Jaka jest cena za Entia Biosciences, Inc. (ERGO)

Cena za Entia Biosciences, Inc. (ERGO) wynosi $0.0002

Jaka jest kapitalizacja rynkowa dla Entia Biosciences, Inc. (ERGO)

Kapitalizacja rynkowa dla Entia Biosciences, Inc. (ERGO) wynosi $6.73K

Entia Biosciences, Inc. (ERGO) Wskaźnik C/Z

Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical food products in the United States. The company develops ErgoD2, a pharmaceutical grade organic compound for the improvement of iron homeostasis and mitigation of iron-related disorders presenting in anemia, chronic kidney disease, and select neurodegenerative diseases. It is also involved in the discovery, scientific evaluation, and marketing of natural formulations that can be used in medical food, nutraceuticals, cosmetics, and other products. In addition, the company offers beauty products under the GROH brand name. It markets its products directly to consumers through e-commerce channels, such as direct email marketing, social media outlets, and e-commerce sites. The company was formerly known as Total Nutraceutical Solutions, Inc. and changed its name to Entia Biosciences, Inc. in January 2012. Entia Biosciences, Inc. was incorporated in 2007 and is headquartered in Sherwood, Oregon.

Rok	Wskaźnik P/E	Zmień
Za mało danych dla podanych dat.

Rok

Wskaźnik P/E

Zmień

Za mało danych dla podanych dat.

Firma	Wskaźnik P/E	Różnica wskaźnika P/E	Kraj
Royalty Pharma plc RPRX.US	23.71	-	US
Swedish Orphan Biovitrum AB SOBI.ST	-	-	SE
Ipsen S.A. IPN.PA	-	-	FR
Recordati Industria Chimica e Farmaceutica S.p.A. REC.MI	-	-	IT
Corcept Therapeutics Incorporated CORT.US	220.17	-	US

Firma

Wskaźnik P/E

Różnica wskaźnika P/E

Kraj